| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Mirum Pharmaceuticals, Inc.
13D/A
Amendment 8
MIRM · 604749101
|
6.8% |
1/27/2026
Event 1/23/2026
|
|||
| Frazier Life Sciences IX, L.P. | 5.9% | ||||
| FHMLS IX, L.P. | 5.9% | ||||
| FHMLS IX, L.L.C. | 5.9% | ||||
| Frazier Life Sciences X, L.P. | 0.8% | ||||
| FHMLS X, L.P. | 0.8% | ||||
| FHMLS X, L.L.C. | 0.8% | ||||
| Frazier Life Sciences Public Fund, L.P. | 4.2% | ||||
| FHMLSP, L.P. | 4.2% | ||||
| FHMLSP, L.L.C. | 4.2% | ||||
| Frazier Life Sciences XI, L.P. | 1.8% | ||||
| FHMLS XI, L.P. | 1.8% | ||||
| FHMLS XI, L.L.C. | 1.8% | ||||
| Frazier Life Sciences XII, L.P. | 0.1% | ||||
| FHMLS XII, L.P. | 0.1% | ||||
| FHMLS XII, L.L.C. | 0.1% | ||||
| James N. Topper | 6.7% | ||||
| Patrick J. Heron | 6.8% | ||||
|
Mirum Pharmaceuticals, Inc.
13D/A
Amendment 7
MIRM · 604749101
|
7.6% |
11/4/2025
Event 11/1/2025
|
|||
| Frazier Life Sciences IX, L.P. | 7.1% | ||||
| FHMLS IX, L.P. | 7.1% | ||||
| FHMLS IX, L.L.C. | 7.1% | ||||
| Frazier Life Sciences X, L.P. | 0.3% | ||||
| FHMLS X, L.P. | 0.3% | ||||
| FHMLS X, L.L.C. | 0.3% | ||||
| Frazier Life Sciences Public Fund, L.P. | 5.0% | ||||
| FHMLSP, L.P. | 5.0% | ||||
| FHMLSP, L.L.C. | 5.0% | ||||
| Frazier Life Sciences XI, L.P. | 1.1% | ||||
| FHMLS XI, L.P. | 1.1% | ||||
| FHMLS XI, L.L.C. | 1.1% | ||||
| James N. Topper | 7.4% | ||||
| Patrick J. Heron | 7.6% | ||||
|
Mirum Pharmaceuticals, Inc.
13D/A
Amendment 6
MIRM · 604749101
|
7.6% |
8/20/2025
Event 8/18/2025
|
|||
| Frazier Life Sciences IX, L.P. | 7.1% | ||||
| FHMLS IX, L.P. | 7.1% | ||||
| FHMLS IX, L.L.C. | 7.1% | ||||
| Frazier Life Sciences X, L.P. | 0.3% | ||||
| FHMLS X, L.P. | 0.3% | ||||
| FHMLS X, L.L.C. | 0.3% | ||||
| Frazier Life Sciences Public Fund, L.P. | 3.1% | ||||
| FHMLSP, L.P. | 3.1% | ||||
| FHMLSP, L.L.C. | 3.1% | ||||
| Frazier Life Sciences Public Overage Fund, L.P. | 1.9% | ||||
| FHMLSP Overage, L.P. | 1.9% | ||||
| FHMLSP Overage, L.L.C. | 1.9% | ||||
| Frazier Life Sciences XI, L.P. | 1.1% | ||||
| FHMLS XI, L.P. | 1.1% | ||||
| FHMLS XI, L.L.C. | 1.1% | ||||
| James N. Topper | 7.4% | ||||
| Patrick J. Heron | 7.6% | ||||
| Albert Cha | 0% | ||||
| James Brush | 0% | ||||
| Daniel Estes | 0% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.